Form D — Cloverleaf Bio, Inc.
0002153574-26-000001 · filed Sep 9, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $29,599,977
- Total sold
- $14,799,988
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cloverleaf Bio, Inc.
- CIK
- 2153574
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 101 COLLEGE STREET, #210
NEW HAVEN, CT 06510 - Phone
- 347-596-9754
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Austin Draycott · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Cole Lewis · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Dima Kuzmin · DirectorNew Haven, CT Find on LinkedIn ↗
-
Christina Vorvis · DirectorNew Haven, CT Find on LinkedIn ↗
-
Matthias Samwer · DirectorNew Haven, CT Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗